These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7925517)

  • 21. Acute hemodynamics of pimobendan in chronic heart failure. A comparative crossover study of captopril and pimobendan.
    Tsuda T; Izumi T; Kodama M; Hanawa H; Takahashi M; Suzuki M; Aizaki T; Uchiyama H; Kuwano H; Shibata A
    Jpn Heart J; 1992 Mar; 33(2):193-203. PubMed ID: 1593749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium sensitization with pimobendan: pharmacology, haemodynamic improvement, and sudden death in patients with chronic congestive heart failure.
    Hagemeijer F
    Eur Heart J; 1993 Apr; 14(4):551-66. PubMed ID: 8472722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical effects of long-term administration of pimobendan in patients with moderate congestive heart failure.
    Sasayama S; Asanoi H; Kihara Y; Yokawa S; Terada Y; Yoshida S; Ejiri M; Horikoshi I
    Heart Vessels; 1994; 9(3):113-20. PubMed ID: 8056717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized cross-over study of enalapril in congestive heart failure: haemodynamic and hormonal effects during rest and exercise.
    Mulligan IP; Fraser AG; Tirlapur V; Lewis MJ; Newcombe RG; Henderson AH
    Eur J Clin Pharmacol; 1988; 34(4):323-31. PubMed ID: 2841136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability of enalapril in congestive heart failure.
    Kjekshus J; Swedberg K
    Am J Cardiol; 1988 Jul; 62(2):67A-72A. PubMed ID: 2839020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group.
    Rector TS; Cohn JN
    Am Heart J; 1992 Oct; 124(4):1017-25. PubMed ID: 1529875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enalapril in chronic heart failure, a double-blind placebo-controlled study.
    Remes J; Nikander P; Rehnberg S; Halinen MO; Kuikka J; Länsimies E; Pyörälä K
    Ann Clin Res; 1986; 18(3):124-8. PubMed ID: 3017174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.
    Sharpe DN; Murphy J; Coxon R; Hannan SF
    Circulation; 1984 Aug; 70(2):271-8. PubMed ID: 6329547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of pimobendan in the management of heart failure.
    Fuentes VL
    Vet Clin North Am Small Anim Pract; 2004 Sep; 34(5):1145-55. PubMed ID: 15325474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of enalapril on clinical status, biochemistry, exercise performance and haemodynamics in heart failure.
    Webster MW; Fitzpatrick MA; Hamilton EJ; Nicholls MG; Ikram H; Espiner EA; Wells JE
    Drugs; 1985; 30 Suppl 1():74-81. PubMed ID: 2994990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of a reduction in haemoglobin concentration by enalapril in stable, moderate heart failure: a double blind study.
    Herrlin B; Nyquist O; Sylvén C
    Br Heart J; 1991 Sep; 66(3):199-205. PubMed ID: 1931347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of intravenous pimobendan (UDCG 115 BS) on hemodynamics and left ventricular volumes in idiopathic dilative cardiomyopathy.
    Permanetter B; Sebening H; Hartmann F; Baumann G; Lutilsky L
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):803-9. PubMed ID: 2481765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular effects and plasma level profile of pimobendan (UD-CG 115 BS) and its metabolite UD-CG 212 in patients with congestive heart failure after single and repeated oral dosing.
    Hagemeijer F; Brand HJ; Roth W
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):302-10. PubMed ID: 2476606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of pimobendan on exercise tolerance and quality of life in patients with heart failure.
    Kubo SH
    Cardiology; 1997; 88 Suppl 2():21-7. PubMed ID: 9142432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of enalapril on cardiac arrhythmias in patients with congestive heart failure.
    Sniezek-Maciejewska M; Czarnecka D; Mroczek-Czernecka D; Kawecka-Jaszcz K
    Cor Vasa; 1992; 34(5-6):382-9. PubMed ID: 1285055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of pimobendan on the incidence of arrhythmias in small breed dogs with myxomatous mitral valve degeneration.
    Lake-Bakaar GA; Singh MK; Kass PH; Griffiths LG
    J Vet Cardiol; 2015 Jun; 17(2):120-8. PubMed ID: 26007710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a fixed-dose combination of benazepril and pimobendan in dogs with congestive heart failure: a randomized non-inferiority clinical trial.
    King JN; Hirakawa A; Sonobe J; Otaki H; Sakakibara N; Seewald W; Forster S
    J Vet Sci; 2018 Jan; 19(1):117-128. PubMed ID: 28693297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of imazodan for treatment of chronic congestive heart failure. The Imazodan Research Group.
    Goldberg AD; Nicklas J; Goldstein S
    Am J Cardiol; 1991 Sep; 68(6):631-6. PubMed ID: 1715125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inotropic agents with calcium-sensitizing properties: clinical and hemodynamic effects of pimobendan.
    Kubo SH
    Coron Artery Dis; 1994 Feb; 5(2):119-26. PubMed ID: 8180743
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of cardiac failure with enalapril].
    Bounhoure JP
    Presse Med; 1985 Dec; 14(44):2215-7. PubMed ID: 3003728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.